Anavex Life Sciences Corp. (AVXL)
4.02
-0.39
(-8.84%)
USD |
NASDAQ |
Dec 10, 13:34
Anavex Life Sciences Market Cap: 359.18M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 385.90M |
| ADMA Biologics, Inc. | 4.728B |
| Aldeyra Therapeutics, Inc. | 286.37M |
| ACADIA Pharmaceuticals, Inc. | 4.549B |
| CorMedix, Inc. | 884.01M |
Market Cap Related Metrics
| PEG Ratio | -1.289 |
| Price to Book Value | 3.786 |
| Price | 4.02 |
| Earnings Yield | -13.53% |
| PEGY Ratio | -1.289 |